UK-based Sareum Holdings, a biotech developing kinase inhibitors for autoimmune disease and cancer, has acquired the licence ...
Sales in Jamjoom Pharmaceuticals Factory Co.’s (Jamjoom Pharma) main markets grew significantly in 2024, with Saudi Arabia ...
Jamjoom Pharma profit up 22% to SAR 356.5M in 2024; Q4 at SAR 51.6M 12 M 2024 Jamjoom Pharma 9M 2024 profit up 23% to 304.9M; Q3 at SAR 95M 9 M 2024 Jamjoom Pharma H1 2024 net profit rises to SAR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback